These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36374572)

  • 1. In vitro activity of fosfomycin alone and in combination against Staphylococcus aureus with reduced susceptibility or resistance to methicillin, vancomycin, daptomycin or linezolid.
    Saravolatz LD; Pawlak J
    J Antimicrob Chemother; 2022 Dec; 78(1):238-241. PubMed ID: 36374572
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Davis KP; McDermott LA; Snydman DR; Aldridge BB
    Microbiol Spectr; 2024 Aug; 12(8):e0097624. PubMed ID: 38916355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of LTX-109, a synthetic antimicrobial peptide, against methicillin-resistant, vancomycin-intermediate, vancomycin-resistant, daptomycin-nonsusceptible, and linezolid-nonsusceptible Staphylococcus aureus.
    Saravolatz LD; Pawlak J; Johnson L; Bonilla H; Saravolatz LD; Fakih MG; Fugelli A; Olsen WM
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4478-82. PubMed ID: 22585222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhodomyrtone: a new anti-
    Saravolatz LD; Pawlak J
    JAC Antimicrob Resist; 2024 Aug; 6(4):dlae097. PubMed ID: 38966334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic bactericidal effects of phage-enhanced antibiotic therapy against MRSA biofilms.
    Kunz Coyne AJ; Stamper K; Bleick C; Kebriaei R; Lehman SM; Rybak MJ
    Microbiol Spectr; 2024 Apr; 12(4):e0321223. PubMed ID: 38411110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
    Tong SY; Nelson J; Paterson DL; Fowler VG; Howden BP; Cheng AC; Chatfield M; Lipman J; Van Hal S; O'Sullivan M; Robinson JO; Yahav D; Lye D; Davis JS;
    Trials; 2016 Mar; 17():170. PubMed ID: 27029920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High activity of Fosfomycin and Rifampin against methicillin-resistant staphylococcus aureus biofilm in vitro and in an experimental foreign-body infection model.
    Mihailescu R; Furustrand Tafin U; Corvec S; Oliva A; Betrisey B; Borens O; Trampuz A
    Antimicrob Agents Chemother; 2014 May; 58(5):2547-53. PubMed ID: 24550327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic comparison of different antimicrobial regimens against Staphylococcus aureus bloodstream infections with elevated vancomycin minimum inhibitory concentration.
    da Costa TM; Cuba GT; Morgado PGM; Nicolau DP; Nouér SA; Dos Santos KRN; Kiffer CRV
    BMC Infect Dis; 2020 Jan; 20(1):74. PubMed ID: 31973753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents.
    Chang J; Tasellari A; Wagner JL; Scheetz MH
    Expert Rev Anti Infect Ther; 2023; 21(12):1309-1325. PubMed ID: 37876291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents.
    Descourouez JL; Jorgenson MR; Wergin JE; Rose WE
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1518-20. PubMed ID: 23263002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro antibacterial effects of Tanreqing injection combined with vancomycin or linezolid against methicillin-resistant Staphylococcus aureus.
    Yang W; Liu J; Blažeković B; Sun Y; Ma S; Ren C; Vladimir-Knežević S; Li C; Xing Y; Tian G; Wang Y
    BMC Complement Altern Med; 2018 May; 18(1):169. PubMed ID: 29848316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of Tedizolid and Comparator Agents Against Gram-positive Isolates Causing Skin and Skin Structure Infections in Pediatric Patients in United States Hospitals (2015-2019).
    Carvalhaes CG; Sader HS; Rhomberg PR; Castanheira M; DeVries S; Mendes RE
    Pediatr Infect Dis J; 2022 Sep; 41(9):731-735. PubMed ID: 35703275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Extracellular DNA in Dalbavancin Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms in Patients with Skin and Soft Tissue Infections.
    Sivori F; Cavallo I; Kovacs D; Guembe M; Sperduti I; Truglio M; Pasqua M; Prignano G; Mastrofrancesco A; Toma L; Pimpinelli F; Morrone A; Ensoli F; Di Domenico EG
    Microbiol Spectr; 2022 Apr; 10(2):e0035122. PubMed ID: 35416701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid bactericidal activity of daptomycin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus peritonitis in mice as measured with bioluminescent bacteria.
    Mortin LI; Li T; Van Praagh AD; Zhang S; Zhang XX; Alder JD
    Antimicrob Agents Chemother; 2007 May; 51(5):1787-94. PubMed ID: 17307984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, Bacteriological, and Genetic Characterization of Bone and Joint Infections Involving Linezolid-Resistant Staphylococcus epidermidis: a Retrospective Multicenter Study in French Reference Centers.
    Coustillères F; Renault V; Corvec S; Dupieux C; Simões PM; Lartigue MF; Plouzeau-Jayle C; Tande D; Lamoureux C; Lemarié C; Chenouard R; Laurent F; Lemaignen A; Bémer P;
    Microbiol Spectr; 2023 Jun; 11(3):e0419022. PubMed ID: 37133395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated at tertiary care hospital in Riyadh, Saudi Arabia.
    Al-Sarar D; Moussa IM; Alhetheel A
    Medicine (Baltimore); 2024 Apr; 103(16):e37860. PubMed ID: 38640320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and Antibacterial Characterization of a New Benzamide FtsZ Inhibitor with Superior Bactericidal Activity and In Vivo Efficacy Against Multidrug-Resistant
    Bryan E; Ferrer-González E; Sagong HY; Fujita J; Mark L; Kaul M; LaVoie EJ; Matsumura H; Pilch DS
    ACS Chem Biol; 2023 Mar; 18(3):629-642. PubMed ID: 36854145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling daptomycin resistance among diverse methicillin-resistant
    Jiang S; Chen M; Zhang J; Ba X; Zhang H; Hong Y; Sun L; Wang Z; Zhuang H; Zhu F; Chen Y; Wang H; Zhao F; Chen Y; Yu Y; Ji S
    Antimicrob Agents Chemother; 2023 Nov; 67(11):e0056323. PubMed ID: 37902403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effectiveness and safety of six antibiotics in treating MRSA infections: A network meta-analysis.
    Ju G; Zhang Y; Ye C; Liu Q; Sun H; Zhang Z; Huang X; Jiang Y; Huang Q
    Int J Infect Dis; 2024 Sep; 146():107109. PubMed ID: 38789000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the molecular basis of reduced vancomycin susceptibility among three prominent
    Malachowa N; Sturdevant DE; Porter AR; Martin G; Martens C; Nair V; Hansen B; Ricklefs S; Jenkins SG; Chen L; Kreiswirth BN; DeLeo FR
    Microbiol Spectr; 2024 Aug; 12(8):e0048624. PubMed ID: 38916317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.